Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000691962 | SCV000819764 | uncertain significance | Intellectual disability, autosomal dominant 5 | 2020-01-22 | criteria provided, single submitter | clinical testing | Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This sequence change replaces arginine with cysteine at codon 41 of the SYNGAP1 protein (p.Arg41Cys). The arginine residue is moderately conserved and there is a large physicochemical difference between arginine and cysteine. This variant is present in population databases (rs762142487, ExAC 0.01%). This variant has been observed in individual(s) with clinical features of SYNGAP1-related conditions (PMID: 30541864, Invitae). |
Diagnostic Laboratory, |
RCV001260775 | SCV001437867 | uncertain significance | Intellectual disability | 2020-09-10 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001771955 | SCV001992496 | likely benign | not provided | 2021-12-08 | criteria provided, single submitter | clinical testing | Reported as a variant of uncertain significance in an individual with myoclonic astatic epilepsy and intellectual disability (Vlaskamp et al., 2019); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 30685520, 30541864) |